|
Product Details:
|
| High Light: | SGS Oral Triptorelin Peptides,GMP Oral Triptorelin Peptides,Triptorelin Hormone Peptide |
||
|---|---|---|---|
Any need pleace Contact Allen:
Whatsapp:+8618971485175
Email:allenraws0437@gmail.com
| Product Name: | Triptorelin | MF: | C64H82N18O13 |
|---|---|---|---|
| MW: | 1311.45 | Specification: | 2 Mg/vial |
| Appearance: | White Powder | Storage Temp: | Below 20°C |
| High Light: |
growth hormone peptides,bodybuilding anabolic steroids |
||
Treatment Of Hormone-responsive Cancers Peptide Triptorelin (2 mg/vial)
Basic Details:
| Product Name | Triptorelin |
| Sequence | Glp-His-Trp-Ser-Tyr-D-Trp-Leu-Arg-Pro-Gly-NH2 |
| Cas No. | 57773-63-4 |
| Molecular Formula | C64H82N18O13 |
| Molecular Weight | 1311.46 |
| Purity (HPLC) | 98.0% min |
| Appearance | White powder |
| Single Impurity (HPLC) | 1.0%max |
Amino Acid Composition |
±10% of theoretical |
| Peptide Content (N%) | ≥80.0% |
| Water Content(Karl Fischer) | ≤6.0% |
| Acetate Content (HPIC) | ≤15.0% |
| MS(ESI) | Consistent |
| Mass Balance | 95.0~105.0% |
| Specific Rotation (20/D) | -65.0~-75.0°(c=0.5 1%HAc) |
Description:
Triptorelin is a gonadotropin-releasing hormone agonist used as the acetate or pamoate salts.
By causing constant stimulation of the pituitary, it decreases pituitary secretion of gonadotropins
luteinizing hormone and follicle stimulating hormone. Like other GnRH agonists, triptorelin may be
used in the treatment of hormone-responsive cancers such as prostate cancer or breast cancer,
precocious puberty, estrogen-dependent conditions, and in assisted reproduction. Triptorelin is
marketed under the brand names Decapeptyl and Diphereline and Gonapeptyl.
Application:
Triptorelin may be used in the treatment of hormone-responsive cancers such as prostate cancer
or breast cancer, precocious puberty, estrogen-dependent conditions, and in assisted
reproduction. Triptorelin is marketed under the brand names Decapeptyl and Diphereline and
Gonapeptyl.
In the United States, it is sold by Watson as Trelstar.In Iran Triptorelin is marketed under the
brand name Variopeptyl.In India, Dr. Reddy's Laboratories has launched recently Triptorelin
under the brand name "Pamorelin LA". During the treatment of prostate cancer it does cause a
surge of testosterone, known as a flare effect. In men a reduction of serum testosterone levels
into the range normally seen after surgical castration occurs approximately two to four weeks
after initiation of therapy.
Triptorelin raises testosterone levels by causing constant stimulation of the pituitary, it decreases
pituitary secretion of gonadotropins luteinizing hormone (LH) and follicle stimulating hormone
(FSH). Like other GnRH agonists, triptorelin may be used in the treatment of hormone-responsive
cancers such as prostate cancer or breast cancer, precocious puberty, estrogen-dependent
conditions (such as endometriosis or uterine fibroids), and in assisted reproduction.
|
Peptide
|
|
| MGF (2mg) | HGH 176-191 (2mg) |
| PEG MGF (2mg) | CJC-1295 (2mg) |
| DSIP (2mg) | CJC-1295 DAC (2mg) |
| TB500 (2mg) | GHRP-2 (5mg / 10mg) |
| Oxytocin (2mg) | GHRP-6 (5mg / 10mg) |
| Hexarelin (2mg) | Selank (5mg) |
| Triptorelin (2mg) | Epitalon (10mg) |
| Ipamorelin (2mg) | PT-141 (10mg) |
| Sermorelin (2mg) | Melanotan I (10mg) |
| Gonadorelin (2mg / 10mg) | Melanotan II (10mg) |
| Tesamorelin (2mg) | ACE031 (1mg) |
| BPC157 (2mg) | Follistatin 315 (1mg) |
| AOD9604 (2mg) | Follistatin 344 (1mg) |
Contact Person: Cameron
Tel: +8618186204104
